Amylyx Pharmaceuticals Inc (AMLX) — Financial Flexibility Index
Amylyx Pharmaceuticals Inc (AMLX) has a Financial Flexibility Index of -1.80x as of March 2026. Free cash flow of $-36.88 Million (operating CF $-36.88 Million minus capex $0.00) represents -2% of total liabilities ($20.44 Million). Check strategic asset allocation of Amylyx Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Amylyx Pharmaceuticals Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Amylyx Pharmaceuticals Inc across 7 annual periods. See Amylyx Pharmaceuticals Inc (AMLX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Amylyx Pharmaceuticals Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Amylyx Pharmaceuticals Inc. For the full company profile including market capitalisation, see Amylyx Pharmaceuticals Inc (AMLX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.50x | $-123.20 Million | $-123.34 Million | $27.39 Million | ▲ +22.5% |
| 2024 | -5.80x | $-167.49 Million | $-167.65 Million | $28.87 Million | ▼ -3804.2% |
| 2023 | 0.16x | $13.16 Million | $11.92 Million | $84.02 Million | ▲ +104.5% |
| 2022 | -3.49x | $-177.34 Million | $-179.87 Million | $50.85 Million | ▼ -1103.1% |
| 2021 | -0.29x | $-74.45 Million | $-74.80 Million | $256.78 Million | ▲ +35.9% |
| 2020 | -0.45x | $-36.55 Million | $-36.70 Million | $80.83 Million | ▼ -22.6% |
| 2019 | -0.37x | $-10.54 Million | $-10.69 Million | $28.58 Million | — |